UPBUpstream Bio, Inc.
- Market cap
- $150.07M
- as of 2026-10-23
- Latest close
- $2.74
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-10-15
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Ambrose AllisonGeneral Counsel | Sep 16 | Sep 17 | S | 485 | $5.49 | Sale −$2,663 | 15,563 | No | Form 4 |
| Gray MichaelCFO and COO | Sep 16 | Sep 17 | S | 853 | $5.49 | Sale −$4,683 | 27,942 | No | Form 4 |
| Houghton AdamChief Business Officer | Sep 16 | Sep 17 | S | 700 | $5.49 | Sale −$3,843 | 22,901 | No | Form 4 |
| Sutherland Everett RandChief Executive Officer | Sep 16 | Sep 17 | S | 2,095 | $5.49 | Sale −$11,502 | 68,717 | No | Form 4 |
| Deykin AaronChief Medical Officer | Sep 16 | Sep 17 | S | 895 | $5.49 | Sale −$4,914 | 32,302 | No | Form 4 |
| Ambrose AllisonGeneral Counsel | Jun 16 | Jun 17 | S | 477 | $6.10 | Sale −$2,910 | 16,048 | No | Form 4 |
| Deykin AaronChief Medical Officer | Jun 16 | Jun 17 | S | 895 | $6.10 | Sale −$5,460 | 33,197 | No | Form 4 |
| Houghton AdamChief Business Officer | Jun 16 | Jun 17 | S | 700 | $6.10 | Sale −$4,270 | 23,601 | No | Form 4 |
| Sutherland Everett RandChief Executive Officer | Jun 16 | Jun 17 | S | 2,095 | $6.10 | Sale −$12,780 | 70,812 | No | Form 4 |
| Gray MichaelCFO and COO | Jun 16 | Jun 17 | S | 853 | $6.10 | Sale −$5,203 | 28,795 | No | Form 4 |
| Chimovits Erez | Jun 9 | Jun 11 | A · derivative | 17,096 | $6.69 | $114,372 | 17,096 | No | Form 4 |
| Ratcliffe Liam | Jun 9 | Jun 11 | A · derivative | 17,096 | $6.69 | $114,372 | 17,096 | No | Form 4 |
| Beckman Daniella | Jun 9 | Jun 11 | A · derivative | 17,096 | $6.69 | $114,372 | 17,096 | No | Form 4 |
| Fleming Harold Edward | Jun 9 | Jun 11 | A · derivative | 17,096 | $6.69 | $114,372 | 17,096 | No | Form 4 |
| Renaud Ronald C JR | Jun 9 | Jun 11 | A · derivative | 17,096 | $6.69 | $114,372 | 17,096 | No | Form 4 |
| Ruddy Marcella K. | Jun 9 | Jun 11 | A · derivative | 17,096 | $6.69 | $114,372 | 17,096 | No | Form 4 |
| Houghton AdamChief Business Officer | Mar 16 | Mar 17 | S | 699 | $9.29 | Sale −$6,494 | 24,301 | No | Form 4 |
| Ambrose AllisonGeneral Counsel | Mar 16 | Mar 17 | S | 475 | $9.29 | Sale −$4,413 | 16,525 | No | Form 4 |
| Sutherland Everett RandChief Executive Officer | Mar 16 | Mar 17 | S | 2,093 | $9.29 | Sale −$19,444 | 72,907 | No | Form 4 |
| Deykin AaronChief Medical Officer | Mar 16 | Mar 17 | S | 894 | $9.29 | Sale −$8,305 | 32,687 | No | Form 4 |
| Gray MichaelCFO and COO | Mar 16 | Mar 17 | S | 852 | $9.29 | Sale −$7,915 | 29,648 | No | Form 4 |
| Sutherland Everett RandChief Executive Officer | Jan 2 | Jan 6 | A | 75,000 | $0.00 | $0 | 75,000 | No | Form 4 |
| Sutherland Everett RandChief Executive Officer | Jan 2 | Jan 6 | A · derivative | 225,000 | $27.07 | $6,090,750 | 225,000 | No | Form 4 |
| Houghton AdamChief Business Officer | Jan 2 | Jan 6 | A | 25,000 | $0.00 | $0 | 25,000 | No | Form 4 |
| Houghton AdamChief Business Officer | Jan 2 | Jan 6 | A · derivative | 75,000 | $27.07 | $2,030,250 | 75,000 | No | Form 4 |
| Ambrose AllisonGeneral Counsel | Jan 2 | Jan 6 | A | 17,000 | $0.00 | $0 | 17,000 | No | Form 4 |
| Ambrose AllisonGeneral Counsel | Jan 2 | Jan 6 | A · derivative | 51,000 | $27.07 | $1,380,570 | 51,000 | No | Form 4 |
| Deykin AaronChief Medical Officer | Jan 2 | Jan 6 | A | 32,000 | $0.00 | $0 | 33,581 | No | Form 4 |
| Deykin AaronChief Medical Officer | Jan 2 | Jan 6 | A · derivative | 96,000 | $27.07 | $2,598,720 | 96,000 | No | Form 4 |
| Gray MichaelCFO and COO | Jan 2 | Jan 6 | A | 30,500 | $0.00 | $0 | 30,500 | No | Form 4 |
| Gray MichaelCFO and COO | Jan 2 | Jan 6 | A · derivative | 91,500 | $27.07 | $2,476,905 | 91,500 | No | Form 4 |
| Ratcliffe Liam | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 17,096 | $11.59 | $198,143 | 17,096 | No | Form 4 |
| Chimovits Erez | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 17,096 | $11.59 | $198,143 | 17,096 | No | Form 4 |
| Fleming Harold Edward | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 17,096 | $11.59 | $198,143 | 17,096 | No | Form 4 |
| Renaud Ronald C JR | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 17,096 | $11.59 | $198,143 | 17,096 | No | Form 4 |
| Beckman Daniella | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 17,096 | $11.59 | $198,143 | 17,096 | No | Form 4 |
| Ruddy Marcella K. | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 17,096 | $11.59 | $198,143 | 17,096 | No | Form 4 |
| Ambrose AllisonGeneral Counsel | Feb 6, 2025 | Feb 7, 2025 | A · derivative | 25,000 | $8.53 | $213,250 | 25,000 | No | Form 4 |
| Deykin AaronChief Medical Officer | Feb 6, 2025 | Feb 7, 2025 | A · derivative | 165,000 | $8.53 | $1,407,450 | 165,000 | No | Form 4 |
| Houghton AdamChief Business Officer | Feb 6, 2025 | Feb 7, 2025 | A · derivative | 140,000 | $8.53 | $1,194,200 | 140,000 | No | Form 4 |
| Gray MichaelCFO and COO | Feb 6, 2025 | Feb 7, 2025 | A · derivative | 195,000 | $8.53 | $1,663,350 | 195,000 | No | Form 4 |
| Sutherland Everett RandChief Executive Officer | Feb 6, 2025 | Feb 7, 2025 | A · derivative | 500,000 | $8.53 | $4,265,000 | 500,000 | No | Form 4 |
| Ambrose AllisonGeneral Counsel | Dec 16, 2024 | Dec 17, 2024 | A · derivative | 100,000 | $19.01 | $1,901,000 | 100,000 | No | Form 4 |
| Orbimed Advisors LLC | Oct 15, 2024 | Oct 17, 2024 | C | 721,956 | not reported | not reported | 973,716 | No | Form 4 |
| Orbimed Advisors LLC | Oct 15, 2024 | Oct 17, 2024 | P | 165,000 | $17.00 | Purchase +$2,805,000 | 1,138,716 | No | Form 4 |
| Orbimed Advisors LLC | Oct 15, 2024 | Oct 17, 2024 | C | 2,887,833 | not reported | not reported | 3,894,873 | No | Form 4 |
| Orbimed Advisors LLC | Oct 15, 2024 | Oct 17, 2024 | P | 660,000 | $17.00 | Purchase +$11,220,000 | 4,554,873 | No | Form 4 |
| Orbimed Advisors LLC | Oct 15, 2024 | Oct 17, 2024 | C · derivative | 524,500 | not reported | not reported | not reported | No | Form 4 |
| Orbimed Advisors LLC | Oct 15, 2024 | Oct 17, 2024 | C · derivative | 2,098,000 | not reported | not reported | not reported | No | Form 4 |
| Orbimed Advisors LLC | Oct 15, 2024 | Oct 17, 2024 | C · derivative | 197,456 | not reported | not reported | not reported | No | Form 4 |
| Orbimed Advisors LLC | Oct 15, 2024 | Oct 17, 2024 | C · derivative | 789,833 | not reported | not reported | not reported | No | Form 4 |
| Chimovits Erez | Oct 15, 2024 | Oct 17, 2024 | C | 721,956 | not reported | not reported | 973,716 | No | Form 4 |
| Chimovits Erez | Oct 15, 2024 | Oct 17, 2024 | P | 165,000 | $17.00 | Purchase +$2,805,000 | 1,138,716 | No | Form 4 |
| Chimovits Erez | Oct 15, 2024 | Oct 17, 2024 | C | 2,887,833 | not reported | not reported | 3,894,873 | No | Form 4 |
| Chimovits Erez | Oct 15, 2024 | Oct 17, 2024 | P | 660,000 | $17.00 | Purchase +$11,220,000 | 4,554,873 | No | Form 4 |
| Chimovits Erez | Oct 15, 2024 | Oct 17, 2024 | C · derivative | 524,500 | not reported | not reported | not reported | No | Form 4 |
| Chimovits Erez | Oct 15, 2024 | Oct 17, 2024 | C · derivative | 2,098,000 | not reported | not reported | not reported | No | Form 4 |
| Chimovits Erez | Oct 15, 2024 | Oct 17, 2024 | C · derivative | 197,456 | not reported | not reported | not reported | No | Form 4 |
| Chimovits Erez | Oct 15, 2024 | Oct 17, 2024 | C · derivative | 789,833 | not reported | not reported | not reported | No | Form 4 |
| Access Industries Holdings LLC | Oct 15, 2024 | Oct 17, 2024 | P | 1,175,000 | $17.00 | Purchase +$19,975,000 | 1,175,000 | Yes | Form 4 |
| Access Industries Holdings LLC | Oct 15, 2024 | Oct 17, 2024 | C | 3,147,000 | not reported | not reported | 4,322,000 | Yes | Form 4 |
| Access Industries Holdings LLC | Oct 15, 2024 | Oct 17, 2024 | C | 1,172,410 | not reported | not reported | 5,494,410 | Yes | Form 4 |
| Access Industries Holdings LLC | Oct 15, 2024 | Oct 17, 2024 | C · derivative | 3,147,000 | not reported | not reported | not reported | Yes | Form 4 |
| Access Industries Holdings LLC | Oct 15, 2024 | Oct 17, 2024 | C · derivative | 1,172,410 | not reported | not reported | not reported | Yes | Form 4 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | Oct 15, 2024 | Oct 15, 2024 | C | 894,733 | not reported | not reported | 894,733 | No | Form 4 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | Oct 15, 2024 | Oct 15, 2024 | C · derivative | 852,940 | $0.00 | $0 | not reported | No | Form 4 |
| Ratcliffe Liam | Oct 10, 2024 | Oct 15, 2024 | A · derivative | 17,096 | $17.00 | $290,632 | 17,096 | No | Form 4 |
| Fleming Harold Edward | Oct 10, 2024 | Oct 15, 2024 | A · derivative | 17,096 | $17.00 | $290,632 | 17,096 | No | Form 4 |
| Ruddy Marcella K. | Oct 10, 2024 | Oct 15, 2024 | A · derivative | 17,096 | $17.00 | $290,632 | 17,096 | No | Form 4 |
| Chimovits Erez | Oct 10, 2024 | Oct 15, 2024 | A · derivative | 17,096 | $17.00 | $290,632 | 17,096 | No | Form 4 |
| Beckman Daniella | Oct 10, 2024 | Oct 15, 2024 | A · derivative | 34,681 | $17.00 | $589,577 | 34,681 | No | Form 4 |
| Renaud Ronald C JR | Oct 10, 2024 | Oct 15, 2024 | A · derivative | 17,096 | $17.00 | $290,632 | 17,096 | No | Form 4 |